CHANGES VIABILITY INDICATORS OF DROSOPHILA MELANOGASTER WHEN USING EXTRACTS REPRESENTATIVES OF THE GENUS MONARDA REGARDING INFLUENCE ANTI-TUMOR DRUGS
O.N. Antosyuk, E.V. Bolotnik · Proceedings of the 1st International Congress "The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies" · 2023
In the course of the analysis of the protective properties of representatives of the genus Monarda, in relation to the antitumor drug methotrexate, a decrease in the lethality of Drosophila melanogaster individuals was found with the simultaneous use of this drug and M. fistulosa extract (100 mg/ml). With regard to exposure to etoposide, protective properties in terms of lethality were determined for extracts of M. fistulosa var. menthifolia and M. didyma.